Galmed Pharmaceuticals Ltd. diskutieren
Galmed Pharmaceuticals Ltd.
WKN: A1XFUX / Symbol: GMED / Name: Galmed Pharma / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
6,40 €
4,84 %
Globus Medical (NYSE:GMED) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
Ratings data for GMED provided by MarketBeat
Globus Medical (NYSE:GMED) had its price target raised by analysts at Royal Bank Of Canada from $92.00 to $100.00. They now have an "outperform" rating on the stock.
Ratings data for GMED provided by MarketBeat
Neueste Beiträge
Roth_Mkm in Discuss Vicor Corp.